Jeremy Tigh, PharmD

Nebraska Medicine, Nebraska Medical Center, Omaha, Nebraska

PCC
Impact of ER Naltrexone on Readmission Rates in Alcohol Use Disorder
Original Research

October 25, 2022

This study evaluated the impact of extended-release intramuscular naltrexone on readmission rates for hospitalized patients with alcohol use disorder.
Jeremy Tigh, Kristin Daniel, Alëna A. Balasanova

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe